[3M01-04] Medical RI production 1

Fri. Sep 8, 2023 9:45 AM - 10:50 AM Room M (ES Bildg. 3F ES034)

Chair:Motomu Suzuki(CRIEPI)

9:45 AM - 10:00 AM

[3M01] R&D on Medical RI production using domestic nuclear infrastructures to achieve self-preparedness (2)

(1) Research Objectives and Summaries

*Naoyuki Takaki¹, Takeo Morooka², Anri Inaki³, Takashi Noda⁴, Shigetaka Maeda⁵ (1. Tokyo City University, 2. NucMed, 3. Kanazawa University, 4. Mitsubishi Heavy Industry, 5. Japan Atomic Energy Agency)

10:00 AM - 10:15 AM

[3M02] R&D on Medical RI production using domestic nuclear infrastructures to achieve self-preparedness (2)

(2)⁹⁹Mo and ²²⁵Ac pharmaceuticals market environment analysis

*Takeo Morooka¹, Yumi Kawata¹, Naoyuki Takaki² (1. Japan Medical Isotope, 2. TCU)

10:15 AM - 10:30 AM

[3M03] R&D on Medical RI production using domestic nuclear infrastructures to achieve self-preparedness (2)

(3) Concept study of Mo/Tc production using PWR power plant (2)

*Takuya Nasu¹, Takafumi Noda¹, Shinichi Tsuburaya¹, Kazuta Kobayashi¹, Shizuka Takahashi¹, Naoyuki Takaki² (1. MHI, 2. TCU)

10:30 AM - 10:45 AM

[3M04] R&D on Medical RI production using domestic nuclear infrastructures to achieve self-preparedness (2)

(4) Development of ⁹⁹Mo/^99mTc production process.

*Kaori Nishikata¹, Misaki Seki¹, Fujita Yoshitaka¹, Tomoaki Takeuchi¹, Hiroshi Ide¹, Kunihiko Tsuchiya¹, Takuya Nasu², Shizuka Takahashi², Kazuta Kobayashi², Naoyuki Takaki³ (1. JAEA, 2. MHI, 3. TCU)

Time reserved for Chair (10:45 AM - 10:50 AM)

Session information

[3M01-04] Medical RI production 1

[3M01] R&D on Medical RI production using domestic nuclear infrastructures to achieve self-preparedness (2)

(1) Research Objectives and Summaries

[3M02] R&D on Medical RI production using domestic nuclear infrastructures to achieve self-preparedness (2)

(2)⁹⁹Mo and ²²⁵Ac pharmaceuticals market environment analysis

[3M03] R&D on Medical RI production using domestic nuclear infrastructures to achieve self-preparedness (2)

(3) Concept study of Mo/Tc production using PWR power plant (2)

[3M04] R&D on Medical RI production using domestic nuclear infrastructures to achieve self-preparedness (2)

(4) Development of ⁹⁹Mo/^99mTc production process.

Authentication

Session information

[3M01-04] Medical RI production 1

[3M01] R&D on Medical RI production using domestic nuclear infrastructures to achieve self-preparedness (2)

(1) Research Objectives and Summaries

[3M02] R&D on Medical RI production using domestic nuclear infrastructures to achieve self-preparedness (2)

(2)99Mo and 225Ac pharmaceuticals market environment analysis

[3M03] R&D on Medical RI production using domestic nuclear infrastructures to achieve self-preparedness (2)

(3) Concept study of Mo/Tc production using PWR power plant (2)

[3M04] R&D on Medical RI production using domestic nuclear infrastructures to achieve self-preparedness (2)

(4) Development of 99Mo/99mTc production process.

Authentication

(2)⁹⁹Mo and ²²⁵Ac pharmaceuticals market environment analysis

(4) Development of ⁹⁹Mo/^99mTc production process.